摘要
目的观察免疫球蛋白治疗小儿重症肺炎的临床效果。方法选取2018年1月到2019年3月到盐城市妇幼保健院接受治疗的34例小儿重症肺炎患者,随机分为观察组17例(基础治疗+免疫球蛋白静滴)与对照组17例(基础治疗),比较两组咳嗽消失时间、肺部啰音消失时间、退热时间、心衰改善时间、住院时间。结果治疗结束,观察组咳嗽消失时间、肺部啰音消失时间、退热时间、心衰改善时间与住院时间指标均短于对照组,差异有显著意义(P<0.05)。结论免疫球蛋白静滴方法可有效改善小儿重症肺炎患者预后。
Objective To observe the clinical effect of immunoglobulin in the treatment of children with severe bronchopneumonia.Methods From January 2018 to March 2019,34 children with severe bronchopneumonia in our hospital were selected and randomly divided into two groups:17 patients in the observation group(basic treatment+intravenous immunoglobulin)and 17 in the control group(basic treatment).The time of cough disappearance,the time of lung ringing disappearance,the time of fever withdrawal,the time of heart failure improvement and the time of hospitalization were compared between the two groups.Results At the end of treatment,the time of cough disappearance,the time of lung ringing disappearance,the time of fever withdrawal,the time of heart failure improvement and the time of hospitalization in the observation group were significantly shorter than those in the control group(P<0.05).Conclusion Immunoglobulin intravenous drip can effectively improve that prognosis of children with severe bronchopneumonia.
作者
刘芹
LIU Qin(Department of Respiration,Yancheng Maternal and Child Health Hospital,Yancheng,Jiangsu 224000,China)
出处
《大医生》
2019年第6期93-94,共2页
Doctor
关键词
重症肺炎
免疫球蛋白
小儿
bronchopneumonia
immunoglobulin
children
